Baoxiniao Holding Future Growth
Future criteria checks 1/6
Baoxiniao Holding is forecast to grow earnings and revenue by 15.9% and 9.4% per annum respectively. EPS is expected to grow by 16% per annum. Return on equity is forecast to be 15.5% in 3 years.
Key information
15.9%
Earnings growth rate
16.0%
EPS growth rate
Luxury earnings growth | 21.9% |
Revenue growth rate | 9.4% |
Future return on equity | 15.5% |
Analyst coverage | Good |
Last updated | 25 Nov 2024 |
Recent future growth updates
Recent updates
The Return Trends At Baoxiniao Holding (SZSE:002154) Look Promising
Sep 26Baoxiniao Holding Co., Ltd.'s (SZSE:002154) Intrinsic Value Is Potentially 96% Above Its Share Price
Jul 12Little Excitement Around Baoxiniao Holding Co., Ltd.'s (SZSE:002154) Earnings
Jun 24Investors Will Want Baoxiniao Holding's (SZSE:002154) Growth In ROCE To Persist
Jun 07Baoxiniao Holding (SZSE:002154) Is Paying Out A Larger Dividend Than Last Year
May 12Baoxiniao Holding's (SZSE:002154) Solid Profits Have Weak Fundamentals
May 03Do Baoxiniao Holding's (SZSE:002154) Earnings Warrant Your Attention?
Mar 28We Think Baoxiniao Holding (SZSE:002154) Can Manage Its Debt With Ease
Feb 27Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,325 | 799 | 537 | 949 | 5 |
12/31/2025 | 5,674 | 681 | 388 | 955 | 6 |
12/31/2024 | 5,240 | 592 | 619 | 716 | 6 |
9/30/2024 | 5,122 | 558 | 570 | 863 | N/A |
6/30/2024 | 5,262 | 634 | 624 | 953 | N/A |
3/31/2024 | 5,316 | 692 | 661 | 1,022 | N/A |
12/31/2023 | 5,254 | 698 | 771 | 1,154 | N/A |
9/30/2023 | 4,942 | 629 | 579 | 945 | N/A |
6/30/2023 | 4,788 | 602 | 523 | 873 | N/A |
3/31/2023 | 4,446 | 509 | 500 | 758 | N/A |
1/1/2023 | 4,313 | 459 | 317 | 515 | N/A |
9/30/2022 | 4,517 | 482 | 302 | 484 | N/A |
6/30/2022 | 4,472 | 467 | 334 | 492 | N/A |
3/31/2022 | 4,614 | 489 | 338 | 507 | N/A |
1/1/2022 | 4,451 | 464 | 474 | 619 | N/A |
9/30/2021 | 4,500 | 493 | 707 | 815 | N/A |
6/30/2021 | 4,390 | 512 | 769 | 845 | N/A |
3/31/2021 | 4,135 | 482 | 696 | 761 | N/A |
12/31/2020 | 3,788 | 366 | 643 | 719 | N/A |
9/30/2020 | 3,364 | 287 | 404 | 497 | N/A |
6/30/2020 | 3,216 | 215 | 297 | 395 | N/A |
3/31/2020 | 3,150 | 184 | 257 | 366 | N/A |
12/31/2019 | 3,273 | 210 | 281 | 396 | N/A |
9/30/2019 | 3,180 | 145 | 182 | 274 | N/A |
6/30/2019 | 3,127 | 124 | 290 | 397 | N/A |
3/31/2019 | 3,144 | 108 | 254 | 359 | N/A |
12/31/2018 | 3,110 | 52 | 232 | 348 | N/A |
9/30/2018 | 3,015 | 129 | 249 | 397 | N/A |
6/30/2018 | 2,866 | 96 | N/A | 431 | N/A |
3/31/2018 | 2,784 | 47 | N/A | 480 | N/A |
12/31/2017 | 2,601 | 26 | N/A | 451 | N/A |
9/30/2017 | 2,348 | -318 | N/A | 369 | N/A |
6/30/2017 | 2,231 | -320 | N/A | 276 | N/A |
3/31/2017 | 2,087 | -382 | N/A | 287 | N/A |
12/31/2016 | 2,008 | -387 | N/A | 278 | N/A |
9/30/2016 | 2,019 | -166 | N/A | 217 | N/A |
6/30/2016 | 2,162 | -73 | N/A | 261 | N/A |
3/31/2016 | 2,134 | 41 | N/A | 239 | N/A |
12/31/2015 | 2,242 | 100 | N/A | 308 | N/A |
9/30/2015 | 2,246 | 173 | N/A | 444 | N/A |
6/30/2015 | 2,280 | 142 | N/A | 411 | N/A |
3/31/2015 | 2,232 | 149 | N/A | 407 | N/A |
12/31/2014 | 2,275 | 134 | N/A | 383 | N/A |
9/30/2014 | 2,062 | 131 | N/A | 298 | N/A |
6/30/2014 | 1,979 | 146 | N/A | 233 | N/A |
3/31/2014 | 2,090 | 164 | N/A | 184 | N/A |
12/31/2013 | 2,018 | 161 | N/A | -45 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 002154's forecast earnings growth (15.9% per year) is above the savings rate (2.8%).
Earnings vs Market: 002154's earnings (15.9% per year) are forecast to grow slower than the CN market (25.9% per year).
High Growth Earnings: 002154's earnings are forecast to grow, but not significantly.
Revenue vs Market: 002154's revenue (9.4% per year) is forecast to grow slower than the CN market (13.8% per year).
High Growth Revenue: 002154's revenue (9.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 002154's Return on Equity is forecast to be low in 3 years time (15.5%).